Back to News
Market Impact: 0.34

JPMorgan reinstates Puma stock coverage with neutral rating

Analyst EstimatesAnalyst InsightsM&A & RestructuringCompany FundamentalsCorporate Guidance & OutlookBanking & Liquidity
JPMorgan reinstates Puma stock coverage with neutral rating

JPMorgan reinstated coverage on Puma with a Neutral rating and a EUR26.00 price target, citing the need for turnaround “cleanup” after merger/activity changes with Anta. The firm projects Puma’s Q2 revenue to fall 9% and an EBIT loss of EUR61m, with profitability pressured near term, alongside weaker fundamentals (revenue -13.5% over 12 months to $8.29B; loss per share of $5.01; debt of $3.34B). Despite this cautious setup, Puma shares rose ~2.3% after Deckers Outdoor beat expectations (net sales $1.12B vs. $1.08B consensus), improving relative investor sentiment.

Analysis

Puma is still in the classic restructuring trap: management is choosing to sacrifice revenue first in order to defend gross margin later, but the market usually pays for that only after two clean quarters of evidence. With a heavy debt load and ongoing EBIT losses, each additional month of “cleanup” increases the odds of either a dilutive financing, a low-premium rescue transaction, or continued multiple compression as investors realize the turnaround is cash-hungry rather than self-funding.

The clearest relative winner is DECK. If Puma is pruning distribution and de-stocking, the shelf space and promotional dollars do not vanish; they migrate toward stronger brands with better sell-through, pricing power, and cleaner inventory. That creates a second-order lift for premium footwear names and a modest tailwind for retailers that can reallocate floor space, while mass-merchant channels like TGT are more likely to see lower traffic in the category and less promotional subsidy from Puma, which may slightly reduce markdown pressure across the sector.

The market may be overpricing the M&A optionality. Strategic chatter can support the stock on headlines over days, but unless there is a real bidder with a financing plan, the equity’s downside is still tied to operating losses and leverage. The key falsifier is a Q2 print showing revenue stabilization plus materially better inventory turns without fresh discounting; absent that, the 1-3 month path is still negative, even if the 6-18 month outcome becomes more interesting on a takeout rumor.

More News